MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Source:http://linkedlifedata.com/resource/pubmed/id/18390844

Download in:

View as

General Info

PMID
18390844